Clinical.Clinical: The FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and prescription benefits manager Medco Health Solutions Medco Health Solutions, Inc. (NYSE: MHS) is a leading pharmacy benefit manager (PBM) company based in Franklin Lakes, New Jersey. The current chairman is David Snow. The company formed in August 2003 as a spinoff from Merck & Co.. have entered into a two-year agreement to study pharmacogenomics. Using reports produced by Medco based on the pharmacy claims of its 60 million members, FDA will assess the use of genetic tests for prescribing drugs and determining drug safety, as well as how doctors utilize such tests. The first targets of the study are likely to be oncology and HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome , but will not be determined until the fall. Medco plans to publish the study's results in a peer-reviewed journal. Medco is also collaborating with the Mayo Clinic on a study of the blood thinner warfarin warfarin (wôr`fərĭn), anticoagulant used to treat blood clots. In large doses it causes bleeding. Warfarin, mixed with bait, is used in rodent control. warfarin Anticoagulant drug, marketed as Coumadin. and with Laboratory Corporation on a study of tamoxifen, a treatment for breast cancer. Source: Reuters |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion